180 Life Sciences Corp. – SYM: ATNF
Recent Price: $0.95
Buyback Action: The Board of Directors approved a new $1.19 million share repurchase program, equal to around 30.09% of its market cap at announcement.
180 Life Sciences Corp., a clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases in the United States. The company product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which has completed phase 2a and phase 2b proof-of-concept clinical trials for early-stage Dupuytren's Contracture; and Synthetic Cannabidiol (CBD) Analogs platform, which are synthetic pharmaceutical grade molecules close or distant analogs of non-psychoactive cannabinoids, such as CBD for the treatment of inflammatory diseases and pain. 180 Life Sciences Corp. is headquartered in Palo Alto, California. |
While Elon Musk's DOGE is getting all the headlines… He just did something that could have far bigger implications for America… and the value of the U.S. dollars in your bank account… and your Social Security checks. |
Summit Hotel Properties, Inc. – SYM: INN
Recent Price: $4.19
Buyback Action: The Board of Directors announced that it had approved a new $50 million share repurchase program, equal to around 11.03% of its market cap at announcement.
Summit Hotel Properties, Inc. is a publicly traded real estate investment trust focused on owning premium-branded lodging facilities with efficient operating models primarily in the upscale segment of the lodging industry. As of February 24, 2025, the Company's portfolio consisted of 97 assets, 53 of which are wholly owned, with a total of 14,553 guestrooms located in 25 states. Click here to continue reading the full article and see our last pick. |
Post a Comment
Post a Comment